Cell Cycle News & Views
Expanding the arsenal: Metformin for the treatment of triple-negative breast cancer?
Downloads and Tools
Volume 8, Issue 17 September 1, 2009
Pages 2681 - 2684
http://dx.doi.org/10.4161/cc.8.17.9502
Authors: Sao Jiralerspong, Ana M. Gonzalez-Angulo and Mien-Chie Hung
View affiliations Hide affiliations
- Sao Jiralerspong
-
MD Anderson Cancer Center; Houston, TX
- Ana M. Gonzalez-Angulo
-
MD Anderson Cancer Center; Houston, TX
- Mien-Chie Hung
-
MD Anderson Cancer Center; Houston, TX
Abstract:
Comment on: Metformin induces unique biological and molecular responses in triple negative breast cancer cells.
Bolin Liu, Zeying Fan, Susan M. Edgerton, Xin-Sheng Deng, Irina N. Alimova, Stuart E. Lind, et al. Cell Cycle 2009; 8:2031–40.
Preview: